media

Markets

Market Nav

RATIO ANALYSIS

You can view the ratio analysis for the last 5 years.
Transgene Biotek Ltd.
ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)-0.79-1.37-1.38-1.45-1.16
Diluted EPS (Rs.)-0.79-1.37-1.38-1.45-1.16
Cash EPS (Rs.)-0.13-0.06-0.06-0.140.14
Book Value[Excl.RevalReserv]/Share (Rs.)1.502.292.944.315.76
Book Value[Incl.RevalReserv]/Share (Rs.)1.502.292.944.315.76
Revenue From Operations / Share (Rs.)0.010.010.020.000.01
PBDIT / Share (Rs.)-0.11-0.03-0.03-0.090.17
PBIT / Share (Rs.)-0.76-1.34-1.34-1.40-1.13
PBT / Share (Rs.)-0.79-1.37-1.38-1.45-1.16
Net Profit / Share (Rs.)-0.79-1.37-1.38-1.45-1.16
NP After MI And SOA / Share (Rs.)-0.79-1.37-1.38-1.45-1.16
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)-1592.36-290.36-153.56-19152.631896.73
PBIT Margin (%)-10578.68-11737.81-5997.29-295958.43-11982.77
PBT Margin (%)-10907.92-11999.39-6154.34-306601.70-12334.24
Net Profit Margin (%)-10907.92-11999.39-6154.34-306601.70-12334.24
NP After MI And SOA Margin (%)-10907.92-11999.39-6154.34-306601.70-12334.24
Return on Networth / Equity (%)-52.85-59.86-46.92-33.55-20.15
Return on Capital Employeed (%)-4.41-7.37-7.12-6.91-5.20
Return On Assets (%)-4.22-7.07-6.65-6.57-4.98
Long Term Debt / Equity (X)0.430.270.200.130.09
Total Debt / Equity (X)1.150.690.500.310.20
      
LIQUIDITY RATIOS     
      
Current Ratio (X)0.080.070.040.040.05
Quick Ratio (X)0.080.060.040.040.04
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)-4.84-1.11-0.97-1.805.40
Interest Coverage Ratio (Post Tax) (%)-32.13-44.87-38.19-27.81-34.09
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)31.9839.3546.0133.0939.34
EV / Net Operating Revenue (X)580.49453.84271.369256.18551.86
EV / EBITDA (X)-36.45-156.30-176.71-48.3329.10
MarketCap / Net Operating Revenue (X)342.50315.51204.686378.80425.15
Price / BV (X)1.661.571.560.690.69
Price / Net Operating Revenue (X)355.71328.18208.180.00444.44
EarningsYield-0.31-0.38-0.30-0.48-0.29
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
PER SHARE RATIOS 
Basic EPS (Rs.)-0.79
Diluted EPS (Rs.)-0.79
Cash EPS (Rs.)-0.13
Book Value[Excl.RevalReserv]/Share (Rs.)1.50
Book Value[Incl.RevalReserv]/Share (Rs.)1.50
Revenue From Operations / Share (Rs.)0.01
PBDIT / Share (Rs.)-0.11
PBIT / Share (Rs.)-0.76
PBT / Share (Rs.)-0.79
Net Profit / Share (Rs.)-0.79
NP After MI And SOA / Share (Rs.)-0.79
PROFITABILITY RATIOS 
PBDIT Margin (%)-1592.36
PBIT Margin (%)-10578.68
PBT Margin (%)-10907.92
Net Profit Margin (%)-10907.92
NP After MI And SOA Margin (%)-10907.92
Return on Networth / Equity (%)-52.85
Return on Capital Employeed (%)-4.41
Return On Assets (%)-4.22
Long Term Debt / Equity (X)0.43
Total Debt / Equity (X)1.15
LIQUIDITY RATIOS 
Current Ratio (X)0.08
Quick Ratio (X)0.08
COVERAGE RATIOS 
Interest Coverage Ratio (%)-4.84
Interest Coverage Ratio (Post Tax) (%)-32.13
VALUATION RATIOS 
Enterprise Value (Cr.)31.98
EV / Net Operating Revenue (X)580.49
EV / EBITDA (X)-36.45
MarketCap / Net Operating Revenue (X)342.50
Price / BV (X)1.66
Price / Net Operating Revenue (X)355.71
EarningsYield-0.31